SCHEMBL4787618

SCHEMBL4787618

Cc1nc(-c2ccccc2)n(C)c1C(=O)NC(=N)N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
C3AR1 Q16581 1/20 0.39
DHODH Q02127 1/20 0.39
NQO2 P16083 1/20 0.38
P2RX7 Q99572 4/20 0.38
ALDH1A1 P00352 3/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.37
KMT2A Q03164 1/20 0.37
LRRK2 Q5S007 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PTGER1 P34995 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4784399 0.88 RAB9A (0.38) CYP1A2ADORA2ADHODHALDH1A1GAA
SCHEMBL4786223 0.85 MAOB (0.46) ADORA2AADORA2BALDH1A1KDM4EKMT2A
SCHEMBL4788478 0.82 HSD11B1 (0.42) ADORA2AALDH1A1SMN1; SMN2
SCHEMBL2682845 0.81 CYP1A2 (0.55) CYP1A2ADORA2AADORA2BDHODHALDH1A1
SCHEMBL11312831 0.78 CYP1A2 (0.58) CYP1A2HDAC1HDAC8HDAC6ADORA2A
Hydrochloric Acid SCHEMBL6312707 0.76 HDAC6 (0.43) HDAC6NQO2ALDH1A1MAPTKMT2A
SCHEMBL4787624 0.75 CYP1A2 (0.49) CYP1A2DHODHPTGER1
SCHEMBL4787412 0.74 TP53 (0.49) HDAC1HDAC8HDAC6ALDH1A1GAA
SCHEMBL4786802 0.73 ALDH1A1 (0.47) ALDH1A1GAAMAPTKDM4EHPGD
Hydrochloric Acid SCHEMBL6313849 0.71 GRM5 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008111794-A1 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-09-18 WO disclosed